Cargando…
KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling
SIMPLE SUMMARY: Killer-cell immunoglobulin-like receptors (KIR) are molecules expressed by the most important cells of the immune system for cancer immune vigilance, natural killer (NK) and effector T cells. In this manuscript we study the role that cytotoxic CD8+ T cells expressing KIR receptors co...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650600/ https://www.ncbi.nlm.nih.gov/pubmed/33076479 http://dx.doi.org/10.3390/cancers12102991 |
_version_ | 1783607513871024128 |
---|---|
author | Gimeno, Lourdes Serrano-López, Emilio M. Campillo, José A. Cánovas-Zapata, María A. Acuña, Omar S. García-Cózar, Francisco Martínez-Sánchez, María V. Martínez-Hernández, María D. Soto-Ramírez, María F. López-Cubillana, Pedro Martínez-Escribano, Jorge Martínez-García, Jerónimo Corbalan-García, Senena Álvarez-López, María R. Minguela, Alfredo |
author_facet | Gimeno, Lourdes Serrano-López, Emilio M. Campillo, José A. Cánovas-Zapata, María A. Acuña, Omar S. García-Cózar, Francisco Martínez-Sánchez, María V. Martínez-Hernández, María D. Soto-Ramírez, María F. López-Cubillana, Pedro Martínez-Escribano, Jorge Martínez-García, Jerónimo Corbalan-García, Senena Álvarez-López, María R. Minguela, Alfredo |
author_sort | Gimeno, Lourdes |
collection | PubMed |
description | SIMPLE SUMMARY: Killer-cell immunoglobulin-like receptors (KIR) are molecules expressed by the most important cells of the immune system for cancer immune vigilance, natural killer (NK) and effector T cells. In this manuscript we study the role that cytotoxic CD8+ T cells expressing KIR receptors could play in cancer immune surveillance. With this objective, frequencies of different KIR+ CD8+ T cell subsets are correlated with the overall survival of patients with melanoma, ovarian and bladder carcinomas. In addition, the gene expression profile of KIR+ CD8+ T cell subsets related to the survival of patients is studied with the aim of discovering new therapeutic targets, so that the outcome of patients with cancer can be improved. ABSTRACT: Killer-cell immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) and effector T cells. Although KIR+ T cells accumulate in oncologic patients, their role in cancer immune response remains elusive. This study explored the role of KIR+CD8+ T cells in cancer immunosurveillance by analyzing their frequency at diagnosis in the blood of 249 patients (80 melanomas, 80 bladder cancers, and 89 ovarian cancers), their relationship with overall survival (OS) of patients, and their gene expression profiles. KIR2DL1+ CD8+ T cells expanded in the presence of HLA-C2-ligands in patients who survived, but it did not in patients who died. In contrast, presence of HLA-C1-ligands was associated with dose-dependent expansions of KIR2DL2/S2+ CD8+ T cells and with shorter OS. KIR interactions with their specific ligands profoundly impacted CD8+ T cell expression profiles, involving multiple signaling pathways, effector functions, the secretome, and consequently, the cellular microenvironment, which could impact their cancer immunosurveillance capacities. KIR2DL1/S1+ CD8+ T cells showed a gene expression signature related to efficient tumor immunosurveillance, whereas KIR2DL2/L3/S2+CD8+ T cells showed transcriptomic profiles related to suppressive anti-tumor responses. These results could be the basis for the discovery of new therapeutic targets so that the outcome of patients with cancer can be improved. |
format | Online Article Text |
id | pubmed-7650600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76506002020-11-10 KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling Gimeno, Lourdes Serrano-López, Emilio M. Campillo, José A. Cánovas-Zapata, María A. Acuña, Omar S. García-Cózar, Francisco Martínez-Sánchez, María V. Martínez-Hernández, María D. Soto-Ramírez, María F. López-Cubillana, Pedro Martínez-Escribano, Jorge Martínez-García, Jerónimo Corbalan-García, Senena Álvarez-López, María R. Minguela, Alfredo Cancers (Basel) Article SIMPLE SUMMARY: Killer-cell immunoglobulin-like receptors (KIR) are molecules expressed by the most important cells of the immune system for cancer immune vigilance, natural killer (NK) and effector T cells. In this manuscript we study the role that cytotoxic CD8+ T cells expressing KIR receptors could play in cancer immune surveillance. With this objective, frequencies of different KIR+ CD8+ T cell subsets are correlated with the overall survival of patients with melanoma, ovarian and bladder carcinomas. In addition, the gene expression profile of KIR+ CD8+ T cell subsets related to the survival of patients is studied with the aim of discovering new therapeutic targets, so that the outcome of patients with cancer can be improved. ABSTRACT: Killer-cell immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) and effector T cells. Although KIR+ T cells accumulate in oncologic patients, their role in cancer immune response remains elusive. This study explored the role of KIR+CD8+ T cells in cancer immunosurveillance by analyzing their frequency at diagnosis in the blood of 249 patients (80 melanomas, 80 bladder cancers, and 89 ovarian cancers), their relationship with overall survival (OS) of patients, and their gene expression profiles. KIR2DL1+ CD8+ T cells expanded in the presence of HLA-C2-ligands in patients who survived, but it did not in patients who died. In contrast, presence of HLA-C1-ligands was associated with dose-dependent expansions of KIR2DL2/S2+ CD8+ T cells and with shorter OS. KIR interactions with their specific ligands profoundly impacted CD8+ T cell expression profiles, involving multiple signaling pathways, effector functions, the secretome, and consequently, the cellular microenvironment, which could impact their cancer immunosurveillance capacities. KIR2DL1/S1+ CD8+ T cells showed a gene expression signature related to efficient tumor immunosurveillance, whereas KIR2DL2/L3/S2+CD8+ T cells showed transcriptomic profiles related to suppressive anti-tumor responses. These results could be the basis for the discovery of new therapeutic targets so that the outcome of patients with cancer can be improved. MDPI 2020-10-15 /pmc/articles/PMC7650600/ /pubmed/33076479 http://dx.doi.org/10.3390/cancers12102991 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gimeno, Lourdes Serrano-López, Emilio M. Campillo, José A. Cánovas-Zapata, María A. Acuña, Omar S. García-Cózar, Francisco Martínez-Sánchez, María V. Martínez-Hernández, María D. Soto-Ramírez, María F. López-Cubillana, Pedro Martínez-Escribano, Jorge Martínez-García, Jerónimo Corbalan-García, Senena Álvarez-López, María R. Minguela, Alfredo KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling |
title | KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling |
title_full | KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling |
title_fullStr | KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling |
title_full_unstemmed | KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling |
title_short | KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling |
title_sort | kir+ cd8+ t lymphocytes in cancer immunosurveillance and patient survival: gene expression profiling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650600/ https://www.ncbi.nlm.nih.gov/pubmed/33076479 http://dx.doi.org/10.3390/cancers12102991 |
work_keys_str_mv | AT gimenolourdes kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT serranolopezemiliom kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT campillojosea kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT canovaszapatamariaa kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT acunaomars kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT garciacozarfrancisco kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT martinezsanchezmariav kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT martinezhernandezmariad kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT sotoramirezmariaf kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT lopezcubillanapedro kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT martinezescribanojorge kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT martinezgarciajeronimo kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT corbalangarciasenena kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT alvarezlopezmariar kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling AT minguelaalfredo kircd8tlymphocytesincancerimmunosurveillanceandpatientsurvivalgeneexpressionprofiling |